Association between the rs2288947 polymorphism of the lncRNA TINCR gene and the risk of recurrent miscarriage in a Southern Chinese population.


Journal

Journal of clinical laboratory analysis
ISSN: 1098-2825
Titre abrégé: J Clin Lab Anal
Pays: United States
ID NLM: 8801384

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 28 02 2019
revised: 01 04 2019
accepted: 27 04 2019
pubmed: 28 5 2019
medline: 7 1 2020
entrez: 25 5 2019
Statut: ppublish

Résumé

Studies have shown that many genes that regulate cell migration are associated with susceptibility to recurrent miscarriage. Terminal differentiation-induced non-coding RNA (TINCR) regulates the migration and invasion of a variety of tumor cells and is associated with susceptibility to various diseases. However, whether the lncRNA TINCR polymorphism is associated with susceptibility to recurrent miscarriage is unclear. Therefore, we investigated the relationship between the rs2288947 A > G polymorphism of the lncRNA TINCR and susceptibility to recurrent abortion. We recruited 248 recurrent spontaneous abortion patients and 392 healthy control subjects from the Southern Chinese population and used the TaqMan method for genotyping. There was no evidence that this polymorphism is associated with recurrent miscarriage (AG vs AA: adjusted OR = 0.904, 95% CI = 0.647-1.264, P = 0.5552; GG and AA: adjusted OR = 0.871, 95% CI = 0.475-1.597, P = 0.6542; dominant model: AG/GG vs AA: adjusted OR = 0.898, 95% CI = 0.653-1.236, P = 0.5101; and recessive model: GG vs AA/AG: adjusted OR = 0.910, 95% CI = 0.505-1.639, P = 0.7527). The stratified analysis also showed no significant associations. This study suggests that the rs2288947 A > G polymorphism of the lncRNA TINCR may not be associated with recurrent miscarriage in a Southern Chinese population. A larger multicenter study is needed to confirm our conclusions.

Identifiants

pubmed: 31124188
doi: 10.1002/jcla.22919
pmc: PMC6642304
doi:

Substances chimiques

RNA, Long Noncoding 0
TINCR lncRNA, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e22919

Subventions

Organisme : Guangdong Natural Science Fund, China
ID : 2016A030313836
Organisme : Guangzhou Medical And Health Technology Projects, China
ID : 20171A011260, 20191A011021, 20191A011033 
Organisme : Guangzhou Science and Technology Program Project, China                                                                      Guangdong Medical Science and Technology Program Project,China: A2017490,A2017608,B2018061 
ID : 201607010011
Organisme : Guangzhou Science and Technology Program Project, China                                                                      Guangdong Medical Science and Technology Program Project,China: A2017490,A2017608,B2018061 
ID : 201804010035, 201904010486

Informations de copyright

© 2019 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc.

Références

Cell Death Dis. 2017 Jun 1;8(6):e2837
pubmed: 28569791
Nature. 2013 Jan 10;493(7431):231-5
pubmed: 23201690
BMC Cancer. 2018 Apr 3;18(1):367
pubmed: 29614984
RNA Biol. 2013 Oct;10(10):1597-601
pubmed: 24019000
Oncogene. 2015 Nov 5;34(45):5648-61
pubmed: 25728677
Biosci Rep. 2017 Jul 27;37(4):
pubmed: 28546230
J Clin Lab Anal. 2019 Jul;33(6):e22919
pubmed: 31124188
Cancer Manag Res. 2018 Aug 20;10:2799-2807
pubmed: 30154672
Am J Reprod Immunol. 2014 Oct;72(4):359-75
pubmed: 24916667
Medicine (Baltimore). 2018 Oct;97(42):e12754
pubmed: 30334961
Biomed Pharmacother. 2018 Mar;99:9-17
pubmed: 29324317
Mol Ther. 2017 Oct 4;25(10):2394-2403
pubmed: 28750739
Reprod Biol Endocrinol. 2017 Dec 01;15(1):92
pubmed: 29195508
Oncotarget. 2017 May 16;8(20):33536-33543
pubmed: 28418933
PLoS One. 2014 Dec 05;9(12):e114781
pubmed: 25479352
Oncotarget. 2016 Dec 27;7(52):87114-87123
pubmed: 27893425
Int J Biol Sci. 2018 Jul 27;14(10):1361-1377
pubmed: 30123082
Oncotarget. 2016 Mar 29;7(13):16012-22
pubmed: 26918601
Gene. 2019 Apr 15;692:223-230
pubmed: 30659947
Fertil Steril. 2017 Jan;107(1):150-159.e2
pubmed: 27842992
J Genet. 2018 Jun;97(2):405-410
pubmed: 29932060
J Huazhong Univ Sci Technolog Med Sci. 2016 Jun;36(3):402-405
pubmed: 27376811
Medicine (Baltimore). 2018 Oct;97(40):e12561
pubmed: 30290617
Am J Reprod Immunol. 2008 Aug;60(2):111-7
pubmed: 18573128
Clin Chim Acta. 2017 Jan;464:17-23
pubmed: 27836685
Obstet Gynecol Clin North Am. 2015 Mar;42(1):117-34
pubmed: 25681844

Auteurs

Wendong Huang (W)

Department of Pharmacy, Maoming People's Hospital, Maoming, China.

Huazhong Zhou (H)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Lei Pi (L)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Yufen Xu (Y)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

LanYan Fu (L)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Yanfang Yang (Y)

Department of Prenatal Diagnosis, Maoming People's Hospital, Maoming, China.

Di Che (D)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Xiaoqiong Gu (X)

Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Department of Blood Transfusion, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Department of Clinical Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH